Targeting Of Somatic Hypermutation By immunoglobulin Enhancer And Enhancer-Like Sequences

PLoS Biology

Volumn 12, Issue 4, 2014, Pages

  Buerstedde, Jean Marie ^a   Alinikula, Jukka ^a   Arakawa, Hiroshi ^b   McDonald, Jessica J ^a   Schatz, David G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR ETS; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); ANTIBODY; CYTIDINE DEAMINASE; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; URACIL DNA GLYCOSIDASE;

ANIMAL CELL; ARTICLE; BINDING SITE; CHICKEN; CONTROLLED STUDY; E BOX ELEMENT; ENHANCER REGION; GENE SEQUENCE; IMMUNOGLOBULIN GENE; INTRON; NONHUMAN; SOMATIC HYPERMUTATION; TRANSCRIPTION INITIATION; ANIMAL; B LYMPHOCYTE; CELL LINE; GENE INACTIVATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; MUTATION; SEQUENCE ALIGNMENT;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; BINDING SITES; CELL LINE; CHICKENS; CYTIDINE DEAMINASE; E-BOX ELEMENTS; ENHANCER ELEMENTS, GENETIC; GENE KNOCKOUT TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; LYMPHOCYTE ACTIVATION; MEF2 TRANSCRIPTION FACTORS; MICE; MUTATION; NF-KAPPA B; SEQUENCE ALIGNMENT; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSCRIPTION, GENETIC; URACIL-DNA GLYCOSIDASE;

EID: 84900400827     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001831     Document Type: Article

References (73)

1. McKean D, Huppi K, Bell M, Staudt L, Gerhard W, et al. (1984) Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A 81: 3180-3184.
2. Kocks C, Rajewsky K, (1988) Stepwise intraclonal maturation of antibody affinity through somatic hypermutation. Proc Natl Acad Sci U S A 85: 8206-8210.
3. Peters A, Storb U, (1996) Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4: 57-65.
4. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
5. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
6. Di Noia J, Neuberger MS, (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419: 43-48.
7. Arakawa H, Saribasak H, Buerstedde JM, (2004) Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate. PLoS Biol 2: e179.
8. Rada C, Di Noia JM, Neuberger MS, (2004) Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol Cell 16: 163-171.
9. Pavri R, Nussenzweig MC, (2011) AID targeting in antibody diversity. Adv Immunol 110: 1-26.
10. Shen HM, Peters A, Baron B, Zhu X, Storb U, (1998) Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280: 1750-1752.
11. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, et al. (1998) BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A 95: 11816-11821.
12. Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, et al. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature 451: 841-845.
13. Betz AG, Milstein C, Gonzalez-Fernandez A, Pannell R, Larson T, et al. (1994) Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell 77: 239-248.
14. Klotz EL, Storb U, (1996) Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer. J Immunol 157: 4458-4463.
15. Goyenechea B, Klix N, Yelamos J, Williams G, Riddell A, et al. (1997) Cells strongly expressing Igk transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J 16: 3987-3994.
16. Yelamos J, Klix N, Goyenechea B, Lozano F, Chui YL, et al. (1995) Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature 376: 225-229.
17. Tumas-Brundage K, Manser T, (1997) The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J Exp Med 185: 239-250.
18. Odegard VH, Schatz DG, (2006) Targeting of somatic hypermutation. Nat Rev Immunol 6: 573-583.
19. Inlay MA, Gao HH, Odegard VH, Lin T, Schatz DG, et al. (2006) Roles of the Ig kappa light chain intronic and 3′ enhancers in Igk somatic hypermutation. J Immunol 177: 1146-1151.
20. van der Stoep N, Gorman JR, Alt FW, (1998) Reevaluation of 3′Ekappa function in stage- and lineage-specific rearrangement and somatic hypermutation. Immunity 8: 743-750.
21. Perlot T, Alt FW, Bassing CH, Suh H, Pinaud E, (2005) Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc Natl Acad Sci U S A 102: 14362-14367.
22. Yoshikawa K, Okazaki IM, Eto T, Kinoshita K, Muramatsu M, et al. (2002) AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296: 2033-2036.
23. Petersen-Mahrt SK, Harris RS, Neuberger MS, (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418: 99-103.
24. Taylor BJ, Nik-Zainal S, Wu YL, Stebbings LA, Raine K, et al. (2013) DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2: e00534.
25. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, et al. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494: 366-370.
26. Pavri R, Gazumyan A, Jankovic M, Di Virgilio M, Klein I, et al. (2010) Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143: 122-133.
27. Basu U, Meng FL, Keim C, Grinstein V, Pefanis E, et al. (2011) The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 144: 353-363.
28. Keim C, Kazadi D, Rothschild G, Basu U, (2013) Regulation of AID, the B-cell genome mutator. Genes Dev 27: 1-17.
29. Buerstedde JM, Takeda S, (1991) Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67: 179-188.
30. Arakawa H, Buerstedde JM, (2009) Activation-induced cytidine deaminase-mediated hypermutation in the DT40 cell line. Philos Trans R Soc Lond B Biol Sci 364: 639-644.
31. Buerstedde JM, Reynaud CA, Humphries EH, Olson W, Ewert DL, et al. (1990) Light chain gene conversion continues at high-rate in an Alv-induced cell-line. EMBO J 9: 921-927.
32. Saribasak H, Saribasak NN, Ipek FM, Ellwart JW, Arakawa H, et al. (2006) Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations. J Immunol 176: 365-371.
33. Kothapalli N, Norton DD, Fugmann SD, (2008) Cutting edge: a cis-acting DNA element targets AID-mediated sequence diversification to the chicken Ig light chain gene locus. J Immunol 180: 2019-2023.
34. Kim Y, Tian M, (2009) NF-kappaB family of transcription factor facilitates gene conversion in chicken B cells. Mol Immunol 46: 3283-3291.
35. Blagodatski A, Batrak V, Schmidl S, Schoetz U, Caldwell RB, et al. (2009) A cis-acting diversification activator both necessary and sufficient for AID-mediated hypermutation. PLoS Genet 5: e1000332.
36. Kohler KM, McDonald JJ, Duke JL, Arakawa H, Tan S, et al. (2012) Identification of core DNA elements that target somatic hypermutation. J Immunol 189: 5314-5326.
37. McDonald JJ, Alinikula J, Buerstedde JM, Schatz DG, (2013) A critical context-dependent role for E boxes in the targeting of somatic hypermutation. J Immunol 191: 1556-1566.
38. Kothapalli NR, Norton DD, Fugmann SD, (2011) Classical Mus musculus Igkappa enhancers support transcription but not high level somatic hypermutation from a V-lambda promoter in chicken DT40 cells. PLoS ONE 6: e18955.
39. Bulfone-Paus S, Reiners-Schramm L, Lauster R, (1995) The chicken immunoglobulin lambda light chain gene is transcriptionally controlled by a modularly organized enhancer and an octamer-dependent silencer. Nucleic Acids Res 23: 1997-2005.
40. Blomberg BB, Rudin CM, Storb U, (1991) Identification and localization of an enhancer for the human lambda L chain Ig gene complex. J Immunol 147: 2354-2358.
41. Combriato G, Klobeck HG, (2002) Regulation of human Ig lambda light chain gene expression by NF-kappa B. J Immunol. 168: 1259-1266.
42. Rudin CM, Storb U, (1992) Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors. Mol Cell Biol 12: 309-320.
43. Satyaraj E, Storb U, (1998) Mef2 proteins, required for muscle differentiation, bind an essential site in the Ig lambda enhancer. J Immunol 161: 4795-4802.
44. Lundqvist ML, McElveen BR, Middleton DL, Warr GW, (2007) Enhancer and promoter activity in the JH to IGHM intron of the Pekin duck, Anas platyrhynchos. Dev Comp Immunol 31: 286-295.
45. Lenardo M, Pierce JW, Baltimore D, (1987) Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236: 1573-1577.
46. Dang W, Nikolajczyk BS, Sen R, (1998) Exploring functional redundancy in the immunoglobulin mu heavy-chain gene enhancer. Mol Cell Biol 18: 6870-6878.
47. Liu ZM, George-Raizen JB, Li S, Meyers KC, Chang MY, et al. (2002) Chromatin structural analyses of the mouse Igkappa gene locus reveal new hypersensitive sites specifying a transcriptional silencer and enhancer. J Biol Chem 277: 32640-32649.
48. Hagman J, Rudin CM, Haasch D, Chaplin D, Storb U, (1990) A novel enhancer in the immunoglobulin lambda locus is duplicated and functionally independent of NF kappa B. Genes Dev 4: 978-992.
49. Hong JW, Hendrix DA, Levine MS, (2008) Shadow enhancers as a source of evolutionary novelty. Science 321: 1314.
50. Schaffner G, Schirm S, Muller-Baden B, Weber F, Schaffner W, (1988) Redundancy of information in enhancers as a principle of mammalian transcription control. J Mol Biol 201: 81-90.
51. Predeus AV, Gopalakrishnan S, Huang Y, Tang J, Feeney AJ, et al. (2014) Targeted chromatin profiling reveals novel enhancers in Ig H and Ig L chain loci. J Immunol 192: 1064-1070.
52. Michael N, Shen HM, Longerich S, Kim N, Longacre A, et al. (2003) The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19: 235-242.
53. Tanaka A, Shen HM, Ratnam S, Kodgire P, Storb U, (2010) Attracting AID to targets of somatic hypermutation. J Exp Med 207: 405-415.
54. Kodama M, Hayashi R, Nishizumi H, Nagawa F, Takemori T, et al. (2001) The PU.1 and NF-EM5 binding motifs in the Ig kappa 3 ′ enhancer are responsible for directing somatic hypermutations to the intrinsic hotspots in the transgenic V-kappa gene. Int Immunol 13: 1415-1422.
55. Luo H, Tian M, (2010) Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells. Mol Immunol 47: 1383-1395.
56. Ronai D, Iglesias-Ussel MD, Fan M, Shulman MJ, Scharff MD, (2005) Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells. Proc Natl Acad Sci U S A 102: 11829-11834.
57. Dunnick WA, Collins JT, Shi J, Westfield G, Fontaine C, et al. (2009) Switch recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region. J Exp Med 206: 2613-2623.
58. Rouaud P, Vincent-Fabert C, Saintamand A, Fiancette R, Marquet M, et al. (2013) The IgH 3′ regulatory region controls somatic hypermutation in germinal center B cells. J Exp Med 210: 1501-1507.
59. Schoetz U, Cervelli M, Wang YD, Fiedler P, Buerstedde JM, (2006) E2A expression stimulates Ig hypermutation. J Immunol 177: 395-400.
60. Kitao H, Kimura M, Yamamoto K, Seo H, Namikoshi K, et al. (2008) Regulation of histone H4 acetylation by transcription factor E2A in Ig gene conversion. Int Immunol 20: 277-284.
61. Conlon TM, Meyer KB, (2006) The chicken Ig light chain 3′-enhancer is essential for gene expression and regulates gene conversion via the transcription factor E2A. Eur J Immunol 36: 139-148.
62. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, et al. (2010) A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 11: 635-643.
63. Bemark M, Neuberger MS, (2000) The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line. Oncogene 19: 3404-3410.
64. Duke JL, Liu M, Yaari G, Khalil AM, Tomayko MM, et al. (2013) Multiple transcription factor binding sites predict AID targeting in non-Ig genes. J Immunol 190: 3878-3888.
65. Rada C, Milstein C, (2001) The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially. EMBO J 20: 4570-4576.
66. Kodgire P, Mukkawar P, Ratnam S, Martin TE, Storb U, (2013) Changes in RNA polymerase II progression influence somatic hypermutation of Ig-related genes by AID. J Exp Med 210: 1481-1492.
67. Sun J, Keim CD, Wang J, Kazadi D, Oliver PM, et al. (2013) E3-ubiquitin ligase Nedd4 determines the fate of AID-associated RNA polymerase II in B cells. Genes Dev 27: 1821-1833.
68. Arakawa H, Kudo H, Batrak V, Caldwell RB, Rieger MA, et al. (2008) Protein evolution by hypermutation and selection in the B cell line DT40. Nucleic Acids Res 36: e1.
69. Arakawa H, Hauschild J, Buerstedde J-M, (2002) Requirement of the activation induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295: 1301-1306.
70. Arakawa H, Lodygin D, Buerstedde JM, (2001) Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol 1: 7.
71. Schug J, (2008) Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics Chapter 2Unit 2.6.
72. Dang W, Sun XH, Sen R, (1998) ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin mu heavy-chain gene enhancer. Mol Cell Biol 18: 1477-1488.
73. Erman B, Cortes M, Nikolajczyk BS, Speck NA, Sen R, (1998) ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol Cell Biol 18: 1322-1330.